Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

European Research Council grant · Running

HormoCaps Gut HORMOne stimulating CAPSules for the treatment of gastrointestinal metabolic disorders

Coordinator
Universite Catholique De Louvain, Belgium
Runs
1 July 2024 to 31 December 2025
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101158056

What the project is doing

In the project's own words, from its summary on CORDIS.

HormoCaps will help us demonstrate the viability as a commercial product of a dual-action drug delivery system which synergizes its own biological effect and that of the encapsulated bioactive molecule for the oral delivery of peptides. This would represent an alternative to current oral incretin-based treatments for gastrointestinal metabolic disorders. In HormoCaps, we will (i) demonstrate the translational feasibility of our strategy; (ii) evaluate the capacity of the formulation to simultaneously stimulate the secretion of hormones that are present at different concentrations at distinct regions of the gastrointestinal mucosa; and (iii) consolidate our results towards a licensing plan to guide the commercialization of our formulation.

Topics

Who is involved

OrganisationCityCountryRole
Universite Catholique De LouvainLouvain La NeuveBelgiumCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI